Information for Physicians

St. Jude has a long history of developing innovative therapies for children with cancer. Phase I and Phase II clinical trials are necessary to define the toxicity and clinical pharmacology of potential anti-cancer agents to be used in future trials. St. Jude has a number of ongoing Phase I and Phase II studies available for children with malignancies that are recurrent, refractory to treatment, or for which no effective therapy exists.

To refer a patient or to obtain further information about Phase I or Phase II clinical trials for which your patient may be eligible, please contact us at recurrentcancer@stjude.org or through our online form in the Related Topics box.

You may wish to refer to Parents: Why St. Jude? for assistance in answering your patient's questions.